Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002570 |
---|---|
Receipt number | R000003099 |
Scientific Title | Phase II study of weekly amrubicin in patients with refractory or relapsed non-small cell lung cancer |
Date of disclosure of the study information | 2009/10/01 |
Last modified on | 2014/05/08 20:51:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/10/01 08:58:26 | ||
2 | Update | 2013/04/01 20:14:05 | Date of closure to data entry Date trial data considered complete |
|
3 | Update | 2013/04/01 20:16:09 | Name of person sending information Organization Division name Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2014/05/08 20:51:52 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Publication of results |